Improving substance abuse treatment enrollment in community syringe exchangers

Addiction

Volumn 104, Issue 5, 2009, Pages 786-795

  Kidorf, Michael ^a,b   King, Van L ^b   Neufeld, Karin ^b   Peirce, Jessica ^b   Kolodner, Ken ^b   Brooner, Robert K ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Harm reduction; Injection drug users; Syringe exchange; Treatment enrollment

Indexed keywords

COCAINE; DIAMORPHINE; METHADONE; OPIATE;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DEPENDENCE TREATMENT; FEMALE; FOLLOW UP; HEALTH PROGRAM; HELP SEEKING BEHAVIOR; HEROIN DEPENDENCE; HUMAN; INTRAVENOUS DRUG ABUSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MONEY; MOTIVATION; PATIENT ATTITUDE; PATIENT REFERRAL; RANDOMIZED CONTROLLED TRIAL; SUSAC SYNDROME;

ADULT; BALTIMORE; DRUG USERS; FEMALE; HARM REDUCTION; HUMANS; MALE; MOTIVATION; NEEDLE-EXCHANGE PROGRAMS; OPIOID-RELATED DISORDERS; REWARD; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 64149098886     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2009.02560.x     Document Type: Article

References (41)

1. Centers for Disease Control (CDC). Syringe exchange programs - United States, 2005. MMWR 2007 56 : 1164 7.
2. Bluthenthal R. N., Kral A., Gee L., Erringer E. A., Edlin B. R. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS 2000 14 : 605 11.
3. Des Jarlais D. C., Marmor M., Paone D., Titus S., Shi Q., Perlis T. et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 1996 348 : 987 91.
4. Des Jarlais D. C., Braine N., Yi H., Turner C. Residual injection risk behavior, HIV Infection, and the evaluation of syringe exchange programs. AIDS Educ Prev 2007 19 : 111 23.
5. Gibson D. R., Flynn N. M., Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 2001 15 : 1329 41.
6. Gibson D. R., Brand R. S., Anderson K., Kahn J. G., Perales D., Guydish J. Two to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. J Acquir Immune Defic Syndr 2002 31 : 237 42.
7. Wodak A., Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse 2006 41 : 777 813.
8. Des Jarlais D. C., Perlis T., Friedman S. R., Chapman T., Kwok J., Rockwell R. et al. Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997. Am J Public Health 2000 90 : 1112 6.
9. Fisher D. G., Fenaughty A. M., Cagle H. H., Wells R. S. Needle exchange and injection drug use frequency: a randomized clinical trial. J Acquir Immune Defic Syndr 2003 33 : 199 205.
10. Van Den Berg C., Smit C., Van Brussel G., Coutinho R., Prins M. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction 2007 102 : 1454 62.
11. Metzger D. S., Navaline H. HIV prevention among injection drug users: the need for integrated models. J Urban Health 2003 80 : 59 66.
12. Sorensen J. L., Copeland A. L. Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend 2000 59 : 17 31.
13. Kidorf M., King V. L. Expanding the public health benefits of syringe exchange programs. Can J Psychiatry 2008 53 : 487 95.
14. Henderson L. A., Vlahov D., Celentano D. D., Strathdee S. A. Readiness for cessation of drug use among recent attenders and nonattenders of a needle exchange program. J Acquir Immune Defic Syndr 2003 32 : 229 37.
15. Kidorf M., Disney E., King V., Kolodner K., Beilenson P., Brooner R. K. Challenges in motivating treatment enrollment in community syringe exchange participants. J Urban Health 2005 82 : 456 67.
16. Heimer R. Can syringe exchange serve as a conduit to substance abuse treatment? J Subst Abuse Treat 1998 15 : 183 91.
17. Riley E. D., Safaeian M., Strathdee S. A., Brooner R. K., Beilenson P., Vlahov D. Drug user treatment referrals and entry among participants of a needle exchange program. Subst Use Misuse 2002 37 : 1869 86.
18. Miller W. R., Rollnick S. Motivational Interviewing: Preparing People for Change, 2nd edn. New York : Guilford Press 2002.
19. Booth R. E., Kwiatkowski C., Iguchi M. Y., Pinto F., John D. Facilitating treatment entry among out-of-treatment injection drug users. Public Health Rep 1998 113 : 116 28.
20. Miller W. R., Zweben A., DiClemente C. C., Rychtarik R. G. Motivational Enhancement Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence. Project MATCH Monograph Series, vol. 2. NIH Publication no. 94-3723. Rockville, MD : National Institute on Alcohol Abuse and Alcoholism 1995.
21. Burke B. L., Arkowitz H., Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol 2003 71 : 843 61.
22. Brooner R. K., Kidorf M., King V. L., Beilenson P., Svikis D., Vlahov D. Drug abuse treatment success among needle exchange participants. Public Health Rep 1998 113 : 129 39.
23. Kidorf M., Disney E. R., King V. L., Neufeld K., Beilenson P. L., Brooner R. K. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug Alcohol Depend 2004 74 : 115 22.
24. Brooner R. K., Kidorf M. S., King V. L., Peirce J. M., Bigelow G. E., Kolodner K. A. Modified 'stepped care' approach to improve attendance behavior in treatment seeking opioid abusers. J Subst Abuse Treat 2004 27 : 223 32.
25. McLellan A. T., Arndt I. O., Metzger D. S., Woody G. E., O'Brien C. P. The effects of psychosocial services in substance abuse treatment. JAMA 1993 269 : 1953 9.
26. Kidorf M., King V.L., Brooner R.K. Counseling and psychosocial services. In : Strain E. C., Stitzer M. L., editors. The Treatment of Opioid Dependence. Baltimore, MD : Johns Hopkins University Press 2006, p. 119 50.
27. Brooner R. K., Kidorf M. S., King V. L., Stoller K. B., Neufeld K. J., Kolodner K. Comparing adaptive stepped care and monetary-based voucher interventions for opioid dependence. Drug Alcohol Depend 2007 88 : S14 23.
28. Kwiatkowski C. F., Booth R. E., Lloyd L. V. The effects of offering free treatment to street-recruited opioid injectors. Addiction 2000 95 : 697 704.
29. Sorensen J. L., Costantini M. F., Wall T. L., Gibson D. R. Coupons attract high-risk untreated heroin users into detoxification. Drug Alcohol Depend 1993 31 : 247 52.
30. Strathdee S. A., Ricketts E. P., Huettner S., Cornelius L., Bishai D., Havens J. R. et al. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: results from a community-based behavioral intervention trial. Drug Alcohol Depend 2006 83 : 225 32.
31. First M. B., Spitzer R. L., Gibbon M., Williams J. B. W. Structured Clinical Interview for DSM-IV Axis Disorders - Patient Edition (SCID-I/P, version 2.0). New York : New York State Psychiatric Institute 1995.
32. Williams J. B. W., Gibbon M., First M. B., Spitzer R. L., Davies M., Borus J. et al. The structured clinical interview for DSM-III-R (SCID) II: multisite test-retest reliability. Arch Gen Psychiatry 1992 49 : 630 6.
33. Kidorf M., Brooner R. K., King V. L., Chutuape M. A., Stitzer M. L. Concurrent validity of cocaine and sedative dependence diagnoses in opioid-dependent outpatients. Drug Alcohol Depend 1996 42 : 117 23.
34. Kidorf M., Brooner R. K., King V. L., Stoller K. B., Wertz J. Predictive validity of cocaine, sedative, and alcohol dependence diagnoses. J Consult Clin Psychol 1998 66 : 168 73.
35. Folstein M. F., Folstein S. E., McHugh P. R. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975 12 : 189 98.
36. McLellan A. T., Lewis D. C., O'Brien C. P., Kleber H. D. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000 284 : 1689 95.
37. Singer J. D., Willett J. B. Modeling the days of our lives: using survival analysis when designing and analyzing longitudinal studies of duration and the timing of events. Psychol Bull 1991 110 : 268 90.
38. Robles R. R., Reyes J. C., Colon H. M., Sahai H., Marrero C. A., Matos T. D. et al. Effects of combined counseling and case management to reduce HIV risk behaviors among Hispanic drug injectors in Puerto Rico: a randomized controlled study. J Subst Abuse Treat 2004 27 : 145 52.
39. Hahn J. A., Vranizan K. M., Moss A. R. Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990. J Acquir Immune Defic Syndr Hum Retrovirol 1997 15 : 157 64.
40. Longshore D., Bluthenthal R. N., Stein M. D. Needle exchange program attendance and injection risk in Providence, Rhode Island. AIDS Educ Prev 2001 13 : 78 90.
41. Ettner S. L., Huang D., Evans E., Ash D. R., Hardy M., Jourabchi M. et al. Benefit-cost in the California treatment outcome project: does substance abuse treatment 'pay for itself'? Health Serv Res 2006 41 : 192 213.